193 related articles for article (PubMed ID: 26464632)
1. Transplantation of mesenchymal stem cells expressing TIMP-1-shRNA improves hepatic fibrosis in CCl₄-treated rats.
Zhu Y; Miao Z; Gong L; Chen W
Int J Clin Exp Pathol; 2015; 8(8):8912-20. PubMed ID: 26464632
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis.
Motawi TM; Atta HM; Sadik NA; Azzam M
Cell Biochem Biophys; 2014 Jan; 68(1):111-25. PubMed ID: 23807535
[TBL] [Abstract][Full Text] [Related]
3. Effect of Function-Enhanced Mesenchymal Stem Cells Infected With Decorin-Expressing Adenovirus on Hepatic Fibrosis.
Jang YO; Cho MY; Yun CO; Baik SK; Park KS; Cha SK; Chang SJ; Kim MY; Lim YL; Kwon SO
Stem Cells Transl Med; 2016 Sep; 5(9):1247-56. PubMed ID: 27365486
[TBL] [Abstract][Full Text] [Related]
4. Anti-fibrotic effects of specific-siRNA targeting of the receptor for advanced glycation end products in a rat model of experimental hepatic fibrosis.
Cai XG; Xia JR; Li WD; Lu FL; Liu J; Lu Q; Zhi H
Mol Med Rep; 2014 Jul; 10(1):306-14. PubMed ID: 24804792
[TBL] [Abstract][Full Text] [Related]
5. [Effect of Panax notoginseng saponins on expressions of MMP-13 and TIMP-1 in rats with hepatic fibrosis].
Jiang H; Xia LZ; Li Y; Li X; Wu J
Zhongguo Zhong Yao Za Zhi; 2013 Apr; 38(8):1206-10. PubMed ID: 23944037
[TBL] [Abstract][Full Text] [Related]
6. Human urokinase-type plasminogen activator gene-modified bone marrow-derived mesenchymal stem cells attenuate liver fibrosis in rats by down-regulating the Wnt signaling pathway.
Ma ZG; Lv XD; Zhan LL; Chen L; Zou QY; Xiang JQ; Qin JL; Zhang WW; Zeng ZJ; Jin H; Jiang HX; Lv XP
World J Gastroenterol; 2016 Feb; 22(6):2092-103. PubMed ID: 26877613
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect of acupuncture on hepatic extracellular matrix production in carbon tetrachloride-induced liver fibrosis rats].
Zhang F; Ma J; Lu Y; Ni GX; Ni CY; Zhang XJ; Wang AY; Zheng SZ
Zhen Ci Yan Jiu; 2012 Feb; 37(1):8-14. PubMed ID: 22574562
[TBL] [Abstract][Full Text] [Related]
8. Mutant MMP-9 and HGF gene transfer enhance resolution of CCl4-induced liver fibrosis in rats: role of ASH1 and EZH2 methyltransferases repression.
Atta H; El-Rehany M; Hammam O; Abdel-Ghany H; Ramzy M; Roderfeld M; Roeb E; Al-Hendy A; Raheim SA; Allam H; Marey H
PLoS One; 2014; 9(11):e112384. PubMed ID: 25380300
[TBL] [Abstract][Full Text] [Related]
9. Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice.
Meier RP; Mahou R; Morel P; Meyer J; Montanari E; Muller YD; Christofilopoulos P; Wandrey C; Gonelle-Gispert C; Bühler LH
J Hepatol; 2015 Mar; 62(3):634-41. PubMed ID: 25450712
[TBL] [Abstract][Full Text] [Related]
10. Fraxinus rhynchophylla ethanol extract attenuates carbon tetrachloride-induced liver fibrosis in rats via down-regulating the expressions of uPA, MMP-2, MMP-9 and TIMP-1.
Peng WH; Tien YC; Huang CY; Huang TH; Liao JC; Kuo CL; Lin YC
J Ethnopharmacol; 2010 Feb; 127(3):606-13. PubMed ID: 20035854
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression.
Rabani V; Shahsavani M; Gharavi M; Piryaei A; Azhdari Z; Baharvand H
Cell Biol Int; 2010 Apr; 34(6):601-5. PubMed ID: 20178458
[TBL] [Abstract][Full Text] [Related]
12. Transplantation of human bone marrow mesenchymal stromal cells reduces liver fibrosis more effectively than Wharton's jelly mesenchymal stromal cells.
Rengasamy M; Singh G; Fakharuzi NA; Siddikuzzaman ; Balasubramanian S; Swamynathan P; Thej C; Sasidharan G; Gupta PK; Das AK; Rahman AZA; Fakiruddin KS; Nian LM; Zakaria Z; Majumdar AS
Stem Cell Res Ther; 2017 Jun; 8(1):143. PubMed ID: 28610623
[TBL] [Abstract][Full Text] [Related]
13. Anti-fibrotic effect of chorionic plate-derived mesenchymal stem cells isolated from human placenta in a rat model of CCl(4)-injured liver: potential application to the treatment of hepatic diseases.
Lee MJ; Jung J; Na KH; Moon JS; Lee HJ; Kim JH; Kim GI; Kwon SW; Hwang SG; Kim GJ
J Cell Biochem; 2010 Dec; 111(6):1453-63. PubMed ID: 20830742
[TBL] [Abstract][Full Text] [Related]
14. Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Hypoxia and the Transforming Growth Factor beta 1 (TGFβ-1) and SMADs Pathway in a Mouse Model of Cirrhosis.
Zhang L; Zhou D; Li J; Yan X; Zhu J; Xiao P; Chen T; Xie X
Med Sci Monit; 2019 Sep; 25():7182-7190. PubMed ID: 31550244
[TBL] [Abstract][Full Text] [Related]
15. [Effects of Shaoqiduogan on MMP-13, TIMP-1 expression in liver and hepatic stellate cells of hepatic fibrosis rats].
Sun W; Gui S; Wu L; Wang H; Wei W
Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(11):1447-51. PubMed ID: 20822018
[TBL] [Abstract][Full Text] [Related]
16. [Oxymatrine could promote mesenchymal stem cell therapy in hepatic fibrosis rats: an experimental research].
Chai NL; Xu SP; Wan J; Wu BY
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jun; 33(6):840-4. PubMed ID: 23980370
[TBL] [Abstract][Full Text] [Related]
17. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
Hu YB; Li DG; Lu HM
J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis.
Su DN; Wu SP; Xu SZ
Stem Cell Res Ther; 2020 Sep; 11(1):395. PubMed ID: 32928296
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic effects of Fuzhenghuayu decoction in a CCl4-induced liver cirrhosis rat model and on hepatic stellate cell activation].
Luo C; Chen ZX; Tan XH; Yi WH; Lu LN; Li YL; Xie SB
Zhonghua Gan Zang Bing Za Zhi; 2013 Sep; 21(9):668-73. PubMed ID: 24160341
[TBL] [Abstract][Full Text] [Related]
20.
Zhang GZ; Sun HC; Zheng LB; Guo JB; Zhang XL
World J Gastroenterol; 2017 Dec; 23(46):8152-8168. PubMed ID: 29290652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
